Search research articles
Contact Us
Filters
Showing results (581-590 of 594) with videos related to
Page
of 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward
Gary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
The Lancet. Digital Health
|
June 2, 2023
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, et al.
Lancet (London, England)
|
December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Steven J Frank, Paul M Busse, J Jack Lee, et al.
Nature
|
October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Adam J Grippin, Christiano Marconi, Sage Copling, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Journal of Medicinal Chemistry
|
February 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease
Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton, et al.
Cancer Discovery
|
April 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 60
Search research articles
Search
Showing results (581-590 of 594) with videos related to
Sort By:
Page
of 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward
Gary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
The Lancet. Digital Health
|
June 2, 2023
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, et al.
Lancet (London, England)
|
December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Steven J Frank, Paul M Busse, J Jack Lee, et al.
Nature
|
October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Adam J Grippin, Christiano Marconi, Sage Copling, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Journal of Medicinal Chemistry
|
February 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease
Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton, et al.
Cancer Discovery
|
April 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 60